ArticleAmerican journal of clinical and experimental urology2015
Combination of 5α-reductase inhibitor with combined androgen blockade (CAB) as a novel cytoreductive regimen before prostate brachytherapy: Ultra-CAB.
Yusuke Muro et al.PubMed ↗Full text ↗
No numbers read from the abstract.